4.6 Article

Sevenfold rise in likelihood of pertussis test requests in a stable set of Australian general practice encounters, 2000-2011

期刊

MEDICAL JOURNAL OF AUSTRALIA
卷 198, 期 11, 页码 624-628

出版社

WILEY
DOI: 10.5694/mja13.10044

关键词

-

资金

  1. Sidney Myer Health Scholarship
  2. Australian Government Department of Health and Ageing
  3. National Prescribing Service
  4. AstraZeneca (Australia)
  5. Merck, Sharp and Dohme (Australia)
  6. Pfizer Australia
  7. Sanofi-Aventis Australia
  8. Novartis Pharmaceuticals Australia
  9. GlaxoSmithKline Australia
  10. CSL Biotherapies
  11. Bayer Australia
  12. Janssen-Cilag
  13. Abbott Australasia
  14. Wyeth Australia
  15. Roche Products
  16. Aventis Pharma

向作者/读者索取更多资源

Objective: To better understand the role that diagnostic test-ordering behaviour of general practitioners has on current pertussis epidemiology in Australia. Design and setting: Analysis of Australian general practice encounter data (from the Bettering the Evaluation and Care of Health [BEACH] program) on 13 pertussis-related problem (PRP) codes that were most likely to result in a pertussis laboratory test request and Australian pertussis notifications data (from the National Notifiable Diseases Surveillance System [NNDSS]) for the period April 2000 to March 2011. Main outcome measures: The change in the proportion of PRP general practice encounters with a pertussis test request between 2000 and 2011, and the change in national pertussis notifications over the same period. Results: The proportion of PRP encounters resulting in a pertussis test request increased from 0.25% between April 2000 and March 2004 to 1.71% between April 2010 and March 2011 (odds ratio, 7.0; 95% Cl, 5.5-8.8). The BEACH data on pertussis testing and NNDSS data on pertussis notifications were highly correlated (r = 0.99), and the notification data mirrored the likelihood of a pertussis test request in general practice. The proportion of NNDSS pertussis notifications with a polymerase chain reaction (PCR)-confirmed diagnosis increased from 16.3% between April 2000 and March 2004 to 65.3% between April 2010 and March 2011. Conclusion: An increase in pertussis testing following recognition of early epidemic cases may have led to identification of previously undetected infections, resulting in a further increase in notified disease and awareness among GPs. The changing likelihood of being tested may also be due to expanding availability and use of PCR testing in Australia.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.6
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据